Patents by Inventor Thomas Joseph Anchordoguy

Thomas Joseph Anchordoguy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200330412
    Abstract: Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Applicant: Cerebral Therapetuics LLC
    Inventors: Daniel J. Abrams, Thomas Joseph Anchordoguy
  • Patent number: 10772857
    Abstract: Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: September 15, 2020
    Assignee: Cerebral Therapeutics, Inc.
    Inventors: Daniel J. Abrams, Thomas Joseph Anchordoguy
  • Publication number: 20190117600
    Abstract: Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.
    Type: Application
    Filed: October 23, 2018
    Publication date: April 25, 2019
    Applicant: Cerebral Therapetuics LLC
    Inventors: Daniel J. Abrams, Thomas Joseph Anchordoguy